Autopsy report · NCT00693342
Vaccine Therapy and OPT-821 or OPT-821 Alone in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer in Complete Remission
Cause of deathSlow enrollment
“Never opened to accrual, a GOG working number, not developed into a clinical trial.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 3
- Sponsor
- Gynecologic Oncology Group
- Sponsor type
- University, hospital or other
- Conditions
- Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
- Interventions
- immunological adjuvant OPT-821; polyvalent antigen-KLH conjugate vaccine
- Participants
- 0
Trials that died the same way
- Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer
“Study closed due to funding, 0 patient accrual.” - Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
“The study was never initiated, no patients were enrolled. It has been closed with the IRB.” - A Study to Evaluate the Efficacy and Safety of REL-1017 As Adjunctive Treatment of Major Depressive Disorder (MDD)
“The study was withdrawn based on business-related matters and there are no new safety concerns related to the trial. No patients were enrolled.” - Effects of Probiotics in Patients With Ulcerative Colitis
“Non applicable clinical trial” - Cannabinoids in Bipolar Affective Disorder
“study was never started and no patients were ever enrolled”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.